Indexed in Journament

journal of clinical oncology : official journal of the american society of clinical oncology

ISSN 1527-7755· EN

Journal Website Certificate of Indexing
Login or register to claim ownership or editorship of this journal.
29.2 / 100
Journament Score
Poor
Ranked #22,705 of 29,324 scored journals (34,008 indexed)
24 Articles
Scores higher than 22.5% of scored journals
050100
The Journament Score is computed from platform statistics — reader engagement, accessibility, publication timeliness, keyword breadth, community impact and content distribution — into a single 0–100 figure, recalculated as new articles and metadata are indexed. Dimensions that cannot be measured for this journal are excluded rather than estimated. It is independent of the paid AI Quality Analysis, which never affects this score or the ranking. Full methodology →

About This Journal

Short Name j clin oncol
Abbreviated Name j clin oncol
ISSN 1527-7755
URL http://www.jco.org

Quality Profile

7 of 12 dimensions measured
This journal Average of scored journals
Platform statistics — the free Journament Score AI Quality Analysis — separate paid product, ranks nothing

5 of the 12 dimensions could not be measured for this journal. They are left as gaps in the shape rather than plotted as zero.

Show the numbers
Dimension This journal Corpus average
Engagement 30.4 30.4
Accessibility 20.0 19.1
Timeliness 0.0 9.2
Diversity 5.6 25.8
Innovation 70.0 27.4
Community Impact 7.9 7.8
Content Distribution 66.7 88.6
Content Quality — 55.5
Ethics & Transparency — 40.2
Editorial Standards — 33.4
Publication Regularity — 53.2
Geographic Reach — 30.8

Publications Per Year

Articles (24)

2000
The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients
Klastersky J;Paesmans M;Rubenstein EB;Boyer M;Elting L;Feld R;Gallagher J;Herrstedt J;Rapoport B;Rolston K;Talcott J;;
Vol. 18 , No. 16 , pp. -
779 views Abstract
2011
First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: final results of an international phase II trial
Vitolo U;Chiappella A;Ferreri AJ;Martelli M;Baldi I;Balzarotti M;Bottelli C;Conconi A;Gomez H;Lopez-Guillermo A;Martinelli G;Merli F;Novero D;Orsucci L;Pavone V;Ricardi U;Storti S;Gospodarowicz MK;Cavalli F;Sarris AH;Zucca E;;
Vol. 29 , No. 20 , pp. -
580 views Abstract
1992
Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule
Talcott JA;Siegel RD;Finberg R;Goldman L;;
Vol. 10 , No. 2 , pp. -
561 views Abstract
2017
Idarubicin Dose Escalation During Consolidation Therapy for Adult Acute Myeloid Leukemia.
Bradstock, Kenneth F;Link, Emma;Di Iulio, Juliana;Szer, Jeff;Marlton, Paula;Wei, Andrew H;Enno, Arno;Schwarer, Anthony;Lewis, Ian D;D'Rozario, James;Coyle, Luke;Cull, Gavin;Campbell, Phillip;Leahy, Michael F;Hahn, Uwe;Cannell, Paul;Tiley, Campbell;Lowenthal, Ray M;Moore, John;Cartwright, Kimberly;Cunningham, Ilona;Taper, John;Grigg, Andrew;Roberts, Andrew W;Benson, Warwick;Hertzberg, Mark;Deveridge, Sandra;Rowlings, Philip;Mills, Anthony K;Gill, Devinder;Bardy, Peter;Campbell, Lynda;Seymour, John F;, ;
Vol. 35 , No. 15 , pp. 1678-1685
517 views DOI Abstract
2019
Management of Osteoporosis in Survivors of Adult Cancers With Nonmetastatic Disease: ASCO Clinical Practice Guideline.
Shapiro, Charles L;Van Poznak, Catherine;Lacchetti, Christina;Kirshner, Jeffrey;Eastell, Richard;Gagel, Robert;Smith, Sean;Edwards, Beatrice J;Frank, Elizabeth;Lyman, Gary H;Smith, Matthew R;Mhaskar, Rahul;Henderson, Tara;Neuner, Joan;
, pp. JCO1901696
468 views DOI Abstract
2000
"Low-risk" prediction rule for pediatric oncology patients presenting with fever and neutropenia
Klaassen RJ;Goodman TR;Pham B;Doyle JJ;;
Vol. 18 , No. 5 , pp. -
444 views Abstract
2006
Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications
Klastersky J;Paesmans M;Georgala A;Muanza F;Plehiers B;Dubreucq L;Lalami Y;Aoun M;Barette M;;
Vol. 24 , No. 25 , pp. -
428 views Abstract
2018
Longer Follow-Up Confirms Relapse-Free Survival Benefit With Adjuvant Dabrafenib Plus Trametinib in Patients With Resected V600-Mutant Stage III Melanoma.
Hauschild, Axel;Dummer, Reinhard;Schadendorf, Dirk;Santinami, Mario;Atkinson, Victoria;Mandalà, Mario;Chiarion-Sileni, Vanna;Larkin, James;Nyakas, Marta;Dutriaux, Caroline;Haydon, Andrew;Robert, Caroline;Mortier, Laurent;Schachter, Jacob;Lesimple, Thierry;Plummer, Ruth;Dasgupta, Kohinoor;Haas, Tomas;Shilkrut, Mark;Gasal, Eduard;Kefford, Richard;Kirkwood, John M;Long, Georgina V;
Vol. 36 , No. 35 , pp. 3441-3449
410 views DOI Abstract
2008
Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group
Scher HI;Halabi S;Tannock I;Morris M;Sternberg CN;Carducci MA;Eisenberger MA;Higano C;Bubley GJ;Dreicer R;Petrylak D;Kantoff P;Basch E;Kelly WK;Figg WD;Small EJ;Beer TM;Wilding G;Martin A;Hussain M; ;;
Vol. 26 , No. 7 , pp. -
398 views Abstract
1994
American Society of Clinical Oncology. Recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines
;
Vol. 12 , No. 11 , pp. -
398 views Abstract
2020
Phase II Study of Pembrolizumab As First-Line, Single-Drug Therapy for Patients With Unresectable Cutaneous Squamous Cell Carcinomas.
Maubec, Eve;Boubaya, Marouane;Petrow, Peter;Beylot-Barry, Marie;Basset-Seguin, Nicole;Deschamps, Lydia;Grob, Jean-Jacques;Dréno, Brigitte;Scheer-Senyarich, Isabelle;Bloch-Queyrat, Coralie;Leccia, Marie-Thérèse;Stefan, Andreea;Saiag, Philippe;Grange, Florent;Meyer, Nicolas;de Quatrebarbes, Julie;Dinulescu, Monica;Legoupil, Delphine;Machet, Laurent;Dereure, Olivier;Zehou, Ouidad;Montaudié, Henri;Wierzbicka-Hainaut, Ewa;Le Corre, Yannick;Mansard, Sandrine;Guégan, Sarah;Arnault, Jean-Philippe;Dalac, Sophie;Aubin, François;Alloux, Céline;Lopez, Isabelle;Cherbal, Soufian;Tibi, Annick;Lévy, Vincent;, ;
, pp. JCO1903357
293 views DOI Abstract
2019
Reply to H. McLeod et al.
Weinstock, Chana;Fernandes, Laura L;Theoret, Marc;Tang, Shenghui;Sridhara, Rajeshwari;Beaver, Julia A;Pazdur, Richard;
, pp. JCO1902429
357 views DOI
2019
Management of Osteoporosis in Survivors of Adult Cancers With Nonmetastatic Disease: ASCO Clinical Practice Guideline.
Shapiro, Charles L;Van Poznak, Catherine;Lacchetti, Christina;Kirshner, Jeffrey;Eastell, Richard;Gagel, Robert;Smith, Sean;Edwards, Beatrice J;Frank, Elizabeth;Lyman, Gary H;Smith, Matthew R;Mhaskar, Rahul;Henderson, Tara;Neuner, Joan;
, pp. JCO1901696
468 views DOI Abstract
2019
Journal Honors Deborah Blythe Doroshow, MD, PhD, As Recipient of the 2019 Journal of Clinical Oncology Young Investigator Award
Melchione, C.
Vol. 37 , pp. 1845-1846
233 views DOI
2019
Human Herpesvirus 6B and Lower Respiratory Tract Disease After Hematopoietic Cell Transplantation.
Hill, Joshua A;Vande Vusse, Lisa K;Xie, Hu;Chung, E Lisa;Yeung, Cecilia C S;Seo, Sachiko;Stevens-Ayers, Terry;Fisher, Cynthia E;Huang, Meei-Li;Stewart, F Marc;Jerome, Keith R;Zerr, Danielle M;Corey, Lawrence;Leisenring, Wendy M;Boeckh, Michael;
, pp. JCO1900908
291 views DOI Abstract
2018
comparing kirkpatrick’s original and new model with cipp evaluation model
;ROGHAYEH GANDOMKAR
Vol. 6 , No. 2 , pp. 94-95
62 views Abstract
2018
Longer Follow-Up Confirms Relapse-Free Survival Benefit With Adjuvant Dabrafenib Plus Trametinib in Patients With Resected V600-Mutant Stage III Melanoma.
Hauschild, Axel;Dummer, Reinhard;Schadendorf, Dirk;Santinami, Mario;Atkinson, Victoria;Mandalà, Mario;Chiarion-Sileni, Vanna;Larkin, James;Nyakas, Marta;Dutriaux, Caroline;Haydon, Andrew;Robert, Caroline;Mortier, Laurent;Schachter, Jacob;Lesimple, Thierry;Plummer, Ruth;Dasgupta, Kohinoor;Haas, Tomas;Shilkrut, Mark;Gasal, Eduard;Kefford, Richard;Kirkwood, John M;Long, Georgina V;
Vol. 36 , No. 35 , pp. 3441-3449
410 views DOI Abstract
2017
Idarubicin Dose Escalation During Consolidation Therapy for Adult Acute Myeloid Leukemia.
Bradstock, Kenneth F;Link, Emma;Di Iulio, Juliana;Szer, Jeff;Marlton, Paula;Wei, Andrew H;Enno, Arno;Schwarer, Anthony;Lewis, Ian D;D'Rozario, James;Coyle, Luke;Cull, Gavin;Campbell, Phillip;Leahy, Michael F;Hahn, Uwe;Cannell, Paul;Tiley, Campbell;Lowenthal, Ray M;Moore, John;Cartwright, Kimberly;Cunningham, Ilona;Taper, John;Grigg, Andrew;Roberts, Andrew W;Benson, Warwick;Hertzberg, Mark;Deveridge, Sandra;Rowlings, Philip;Mills, Anthony K;Gill, Devinder;Bardy, Peter;Campbell, Lynda;Seymour, John F;, ;
Vol. 35 , No. 15 , pp. 1678-1685
517 views DOI Abstract
2016
the effect of web quest and team-based learning on students’ self-regulation
;ZOHREH BADIYEPEYMAIE JAHROMI;LEILI MOSALANEJAD;RITA REZAEE
Vol. 4 , No. 2 , pp. 80-87
211 views Abstract
2016
social media and impression management: veterinary medicine students’ and faculty members’ attitudes toward the acceptability of social media posts
;APRIL A. KEDROWICZ;KENNETH ROYAL;KEVEN FLAMMER
Vol. 4 , No. 4 , pp. 155-162
212 views Abstract
Journament Score
29.2/100 · Poor
Ranked #22,705 of 29,324 scored
(34,008 journals indexed)
Platform Statistics
AI Quality Analysis
Separate paid analysis — does not affect ranking.
Journament

Overall Quality Score

29.2/100

Tier: Poor

The Journament Overall Quality Score is a comprehensive metric that evaluates academic journals across multiple dimensions including engagement, accessibility, diversity, innovation, and community impact.

This score helps researchers, institutions, and publishers understand the holistic quality and impact of a journal beyond traditional metrics.

Engagement Score

30.4/100

Measures user interactions, views, citations, and community involvement with this journal's content.

Higher engagement scores indicate that the journal's content is actively being read, cited, and discussed within the academic community.

Accessibility Score

20.0/100

Evaluates how easily researchers can access journal content, including open access availability, ISSN registration, and indexing.

This metric considers factors such as paywalls, open access policies, and availability across different academic databases and search engines.

Diversity Score

5.6/100

Assesses geographic and institutional diversity of authors, editorial board composition, and topic breadth.

A diverse journal publishes work from various geographic regions, institutions, and covers a broad range of topics within its field.

Innovation Score

70.0/100

Evaluates research novelty, interdisciplinary work, and emerging topics based on AI analysis of article abstracts.

This score reflects how much the journal publishes cutting-edge research, explores new methodologies, and bridges different academic disciplines.

Community Impact Score

7.9/100

Measures scholarly contribution and real-world applications of published research.

This metric evaluates how the journal's research translates into practical applications, policy changes, and benefits to society beyond academia.

Timeliness Score

0.0/100

Evaluates recent publication activity, publication frequency, and currency of research topics.

Higher scores indicate consistent publishing schedules and timely coverage of current research trends.

Content Distribution

66.7/100

Measures how evenly reader attention spreads across the journal's articles, using the Gini coefficient of article clicks.

Higher scores mean readership is distributed across many articles rather than concentrated on one or two.

Ethics & Transparency Score

Not yet measured

Research Integrity (10% weight)

Assesses COPE standards compliance, ethical considerations in research, transparency in methodologies, and reproducibility practices.

This metric ensures the journal maintains high ethical standards and promotes transparent, trustworthy research.

Content Quality Score

Not yet measured

Academic Rigor (20% weight) + Methodology Quality (12%)

Evaluates research methodology soundness, statistical rigor, theoretical framework strength, appropriateness of research methods, data quality, and clarity & readability.

This comprehensive metric ensures published research meets the highest academic standards.

Editorial Diversity Score

Not yet measured

Author Diversity + Interdisciplinary Value (8%)

Measures geographic diversity of authors, institutional variety, editorial board composition, and cross-disciplinary connections.

Diverse editorial teams bring varied perspectives and reduce bias in academic publishing.

Publication Regularity Score

Not yet measured

Assesses consistency of publication schedule, frequency stability, and predictable output patterns.

Regular publication schedules indicate reliable journal operations and consistent workflow management.

Geographic Reach Score

Not yet measured

Evaluates international author representation, global readership distribution, and cross-border research collaboration.

Wide geographic reach indicates global impact and international recognition of the journal's research.